Maze Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	316.77	196.81	29.16	99.92
Short-Term Investments	67.16	-	-	-
Cash & Short-Term Investments	383.94	196.81	29.16	99.92
Cash Growth	156.63%	574.99%	-70.82%	-
Other Current Assets	7.37	4.86	4.95	6.23
Total Current Assets	391.3	201.67	34.11	106.15
Net Property, Plant & Equipment	26.46	29.92	34.98	41.23
Other Long-Term Assets	4.3	8.95	2.41	2.58
Total Assets	422.06	240.54	71.5	149.96
Accounts Payable	2.92	1.94	2.02	1.59
Accrued Expenses	14.43	14.1	9.81	14.87
Current Portion of Leases	4.76	4.63	4.49	4.32
Total Current Liabilities	22.11	20.67	16.32	20.78
Long-Term Debt	-	-	20.08	-
Long-Term Leases	19.42	22	25.05	27.73
Other Long-Term Liabilities	1.09	0.97	-	-
Total Long-Term Liabilities	20.51	22.97	45.13	27.73
Total Liabilities	42.62	43.64	61.45	48.51
Common Stock	0.05	0	0	0
Additional Paid-in Capital	834.3	47.24	21.84	12.81
Accumulated Other Comprehensive Income	0.07	-	-	-
Retained Earnings	-454.98	-358.43	-395.69	-295.27
Minority Interest	-	508.09	383.9	383.9
Shareholders' Equity	379.44	-311.18	-373.85	-282.46
Total Liabilities & Equity	422.06	240.54	71.5	149.96
Total Debt	24.18	26.63	49.62	32.06
Net Cash (Debt)	359.75	170.18	-20.47	67.86
Net Cash Growth	111.39%	-	-	-
Net Cash Per Share	12.10	62.33	-8.95	33.78
Book Value	379.44	-311.18	-373.85	-282.46
Book Value Per Share	12.76	-113.97	-163.40	-140.59
Tangible Book Value	379.44	-311.18	-373.85	-282.46
Tangible Book Value Per Share	12.76	-113.97	-163.40	-140.59

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q